Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APALUTAMIDE for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 3,286 adverse event reports in the FDA FAERS database where APALUTAMIDE was used for Prostate cancer.

Most Reported Side Effects for APALUTAMIDE

Side Effect Reports % Deaths Hosp.
Rash 1,117 11.7% 47 225
Death 1,008 10.6% 991 45
Fatigue 824 8.6% 21 106
Hot flush 532 5.6% 12 61
Product dose omission issue 384 4.0% 1 24
Diarrhoea 317 3.3% 6 64
Asthenia 303 3.2% 13 67
Dizziness 294 3.1% 7 38
Fall 268 2.8% 20 133
Off label use 257 2.7% 32 44
Decreased appetite 255 2.7% 17 83
Arthralgia 253 2.7% 3 36
Prostatic specific antigen increased 251 2.6% 11 37
Pruritus 224 2.4% 5 59
Hospitalisation 209 2.2% 5 202

Other Indications for APALUTAMIDE

Product used for unknown indication (4,070) Prostate cancer metastatic (659) Hormone-dependent prostate cancer (533) Hormone-refractory prostate cancer (365) Neoplasm malignant (48) Prostate cancer stage 0 (25) Metastases to bone (17) Neoplasm prostate (17) Prostate cancer stage iv (13) Prostatic specific antigen increased (11)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627) DOCETAXEL (1,551)

Related Pages

APALUTAMIDE Full Profile All Prostate cancer Drugs APALUTAMIDE Demographics APALUTAMIDE Timeline